Autologous Tendon Therapy
Chronic tendon injuries
ClinicalPhase 2/3; >1,000 patients treated
Key Facts
Indication
Chronic tendon injuries
Phase
Clinical
Status
Phase 2/3; >1,000 patients treated
Company
About Orthocell
Regenerative medicine firm delivering collagen devices and autologous cell therapies for musculoskeletal and nerve repair.
View full company profile